Effects of hormone replacement therapy on bone mineral density in Turkish patients with or without COL1A1 Sp1 binding site polymorphism

Journal of Obstetrics and Gynaecology Research

Volumn 34, Issue 1, 2008, Pages 73-77

  Simsek, Mehmet ^a   Cetin, Zafer ^a   Bilgen, Turker ^a   Taskin, Omur ^a   Luleci, Guven ^a   Keser, Ibrahim ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Bone mineral density; COL1A1 polymorphism; Hormone replacement therapy; Postmenopausal women

Indexed keywords

CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; TRANSCRIPTION FACTOR SP1;

ADULT; ALLELE; ARTICLE; BINDING SITE; BODY WEIGHT; BONE DENSITY; BONE STRENGTH; COL1A1 GENE; COMPARATIVE STUDY; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; FRAGILITY FRACTURE; GENE; GENETIC POLYMORPHISM; HOMOZYGOSITY; HORMONE SUBSTITUTION; HUMAN; LUMBAR SPINE; MENOPAUSE; NORMAL HUMAN; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SIDE EFFECT; TIME SERIES ANALYSIS;

ABSORPTIOMETRY, PHOTON; BONE DENSITY; CASE-CONTROL STUDIES; COLLAGEN TYPE I; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; ESTROGENS, CONJUGATED (USP); EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MEDROXYPROGESTERONE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SP1 TRANSCRIPTION FACTOR; TURKEY;

EID: 38449085645     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2007.00680.x     Document Type: Article

References (21)

1. Stewart TL, Ralston SH. Role of genetic factors in the pathogenesis of osteoporosis. J Endocrinol 2000 166 : 235 245.
2. Grant SFA, Reid DM, Blake G, Herd R, Fogelman I, Ralston SH. Reduced bone density and osteoporosis associated with a polymorphic Sp1 site in the collagen type I alpha 1 gene. Nat Genet 1996 14 : 203 205.
3. Alvarez L, Oriola J, Jo J et al. Collagen type I alpha1 gene Sp1 polymorphism in premenopausal women with primary osteoporosis: improved detection of Sp1 binding site polymorphism in the collagen type 1 gene. Clin Chem 1999 45 : 904 906.
4. Keen RW, Woodford-Richens KL, Grant SFA, Ralston SH, Lanchbury JS, Spector TD. Association of polymorphism at the type I collagen (COL1A1) locus with reduced bone mineral density, increased fracture risk, and increased collagen turnover. Arthritis Rheum 1999 42 : 285 290.
5. Roux C, Dougados M, Abel L, Mercier G, Lucotte G. Association of a polymorphism in the collagen I 1 gene with osteoporosis in French women. Arthritis Rheum 1998 41 : 187 188.
6. Garnero P, Borel O, Grant SFA, Ralston SH, Delmas PD. Collagen I 1 polymorphism, bone mass and bone turnover in healthy French pre-menopausal women: the OFELY study. J Bone Miner Res 1998 13 : 813 818.
7. Hampson G, Evans C, Petitt RJ et al. Bone mineral density, collagen type 1 alpha 1 genotypes and bone turnover in pre menopausal women with diabetes mellitus. Diabetologia 1998 41 : 1314 1320.
8. Byers PH. Brittle bones-fragile molecules: disorders of collagen gene structure and expression. Trends Genet 1990 6 : 293 300.
9. Mann V, Hobson EE, Li B et al. A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. J Clin Invest 2001 107 : 899 907.
10. Langdahl BL, Ralston SH, Grant SFA, Eriksen EF. A Sp1 binding site polymorphism in the COLIA1 gene predicts osteoporotic fractures in men and women. J Bone Miner Res 1998 13 : 1384 1389.
11. Weichetova M, Stepan JJ, Michalska D et al. COLIA1 polymorphism contributes to bone mineral density to assess prevalent wrist fractures. Bone 2000 26 : 287 290.
12. McGuigan FE, Reid DM, Ralston SH. Susceptibility to osteoporotic fracture is determined by allelic variation at the Sp1 site, rather than other polymorphic sites, at the COLIA1 locus. Osteoporos Int 2000 11 : 338 343.
13. Sowers M, Willing M, Burns T et al. Genetic markers, bone mineral density and serum osteocalcin levels. J Bone Miner Res 1999 14 : 1411 1419.
14. Hustmyer FG, Lui G, Johnston CC, Christian J, Peacock M. Polymorphism at an Sp1 binding site of COLIA1 and bone mineral density in pre-menopausal female twins and elderly fracture patients. Osteoporos Int 1999 9 : 346 350.
15. Uitterlinden AG, Burger H, Huang Q et al. Relation of alleles of the collagen type I 1 gene to bone density and risk of osteoporotic fractures in postmenopausal women. N Engl J Med 1998 338 : 1016 1022.
16. Zajickova K, Zofkova I, Hill M. Is the Sp1 polymorphism in the COL1A1 gene a risk factor for postmenopausal osteoporosis? Comment on the article by Keen et al. Arthritis Rheum 2002 46 : 2828 2829.
17. Liden M, Wilen B, Ljunghall S, Melhus H. Polymorphism at the Sp 1 binding site in the collagen type I alpha 1 gene does not predict bone mineral density in postmenopausal women in Sweden. Calcif Tissue Int 1998 63 : 293 295.
18. Heegaard A, Jorgensen HL, Vestergaard AW, Hassager C, Ralston SH. Lack of influence of collagen type I alpha1 Sp1 binding site polymorphism on the rate of bone loss in a cohort of postmenopausal Danish women followed for 18 years. Calcif Tissue Int 2000 66 : 409 413.
19. Pedersen AT, Ottesen B. Issues to debate on the Women's Health Initiative (WHI) study. Epidemiology or randomized clinical trials - time out for hormone replacement therapy studies? Hum Reprod 2003 18 : 2241 2244.
20. Qureshi AM, Herd RJ, Blake GM, Fogelman I, Ralston SH. COL1A1 Sp1 polymorphism predicts response of femoral neck bone density to cyclical etidronate therapy. Calcif Tissue Int 2002 70 : 158 163.
21. Mann V, Ralston SH. Meta-analysis of COL1A1 Sp1 polymorphism in relation to bone mineral density and osteoporotic fracture. Bone 2003 32 : 711 717.